IRF8 and diffuse large B-cell lymphoma: To examine this possibility, we first expanded the panel of DLBCL models and generated IRF8 KO models in two additional activated B-cell (ABC)-like cell lines, RIVA (RI-1) and SU-DHL2 (Fig. 5A).